Cargando…

A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)

Detalles Bibliográficos
Autores principales: Philipose, Sonia, Ofner, Martina, Heinemann, Ákos, Schuligoi, Rufina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016526/
http://dx.doi.org/10.1186/1471-2210-10-S1-A17
_version_ 1782195764095614976
author Philipose, Sonia
Ofner, Martina
Heinemann, Ákos
Schuligoi, Rufina
author_facet Philipose, Sonia
Ofner, Martina
Heinemann, Ákos
Schuligoi, Rufina
author_sort Philipose, Sonia
collection PubMed
description
format Text
id pubmed-3016526
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30165262011-01-07 A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4) Philipose, Sonia Ofner, Martina Heinemann, Ákos Schuligoi, Rufina BMC Pharmacol Meeting Abstract BioMed Central 2010-11-16 /pmc/articles/PMC3016526/ http://dx.doi.org/10.1186/1471-2210-10-S1-A17 Text en Copyright ©2010 Schuligoi et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Philipose, Sonia
Ofner, Martina
Heinemann, Ákos
Schuligoi, Rufina
A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title_full A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title_fullStr A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title_full_unstemmed A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title_short A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
title_sort biological target for antiplatelet therapy: the prostaglandin e(2) receptor ep(4)
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016526/
http://dx.doi.org/10.1186/1471-2210-10-S1-A17
work_keys_str_mv AT philiposesonia abiologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT ofnermartina abiologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT heinemannakos abiologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT schuligoirufina abiologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT philiposesonia biologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT ofnermartina biologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT heinemannakos biologicaltargetforantiplatelettherapytheprostaglandine2receptorep4
AT schuligoirufina biologicaltargetforantiplatelettherapytheprostaglandine2receptorep4